HOME Top Market Reports 3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021

3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: January 2017
Report Code: BT 4971

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The 3D bioprinting market is expected to reach USD 1,332.6 Million by 2021 from USD 411.4 Million in 2016, at a CAGR of 26.5% during the forecast period. Rising demand for organ transplantation, growing R&D, increasing public and private investments in research, and rising use of 3D bioprinting in drug discovery are driving the growth of this market. However, a lack of complete automation in 3D bioprinting and socio-ethical concerns related to the use of 3D-bioprinted products are the major challenges in this market.

The emerging Asia-Pacific market offers growth opportunities for companies engaged in the development and manufacturing of 3D bioprinters and bioprinted products. Growing demand for organ transplantation, rising initiatives by market players, and increasing stem cell research are the key factors propelling the growth of the 3D bioprinting market in this region.

A combination of bottom-up and top-down approaches was used to calculate the sizes and growth rates of the 3D bioprinting market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative & qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each product segment across the globe. The report provides qualitative insights about the growth rates and market drivers for all subsegments and regions.

Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), Nano3D Biosciences, Inc. (U.S), Cyfuse Biomedical K.K. (Japan), BioBots (U.S.), Aspect Biosystems Ltd. (Canada), 3Dynamic Systems Ltd. (U.K.), regenHU Ltd (Switzerland), Cellink (Sweden), Regenovo Biotechnology Co., Ltd. (China), Poietis (France), and GeSiM (Germany) are some of the key players in the 3D bioprinting market.

Target Audience:

  • 3D bioprinter manufacturers, suppliers, and distributors
  • Pharmaceutical & biotechnology companies
  • Cosmetic product manufacturers, suppliers, and distributors
  • Healthcare institutions
  • Clinical centers
  • Medical research laboratories
  • Academic medical centers and universities
  • Business research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the 3D bioprinting market into the following segments:

Global 3D Bioprinting Market, by Technology

  • Magnetic 3D Bioprinting
  • Laser-assisted Bioprinting
  • Inkjet 3D Bioprinting
  • Microextrusion 3D Bioprinting

Global 3D Bioprinting Market, by Material

  • Living Cells
  • Extracellular Matrices
  • Hydrogels
  • Other Biomaterials
  • *Other biomaterials include alginate, gelatin, and fibrinogen, among others

Global 3D Bioprinting Market, by Application

  • Clinical Applications      
  • Skin
  • Bone
  • Blood Vessels
  • Research Applications  
  • Drug and Medical Research
  • Regenerative Medicine
  • 3D Cell Culture

Global 3D Bioprinting Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the 3D bioprinting market

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
    1.5 Years Considered for the Study
    1.6 Currency
    1.7 Limitations
    1.8 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Methodology Steps
           2.1.1 Secondary and Primary Research Methodology
                    2.1.1.1 Secondary Research
                    2.1.1.2 Key Data From Secondary Sources
                    2.1.1.3 Primary Research
                    2.1.1.4 Key Data From Primary Sources
                    2.1.1.5 Key Industry Insights
    2.2 Market Size Estimation Methodology
    2.3 Research Design
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 27)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 32)
    4.1 3D Bioprinting: Market Overview
    4.2 Geographic Analysis: 3D Bioprinting Market, By Technology (2016)
    4.3 Market Size, By Material, 2016 vs 2021 (USD Million)
    4.4 Market Size, By Application, 2016 vs 2021 (USD Million)
    4.5 Geographic Snapshot of the 3D Bioprinting Market

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Growing Demand for Organ Transplantation
                    5.2.1.2 Rise in Public and Private Funding to Support 3D Bioprinting Research Activities
                    5.2.1.3 Increasing Use of 3D Bioprinting in the Drug Discovery Process
                    5.2.1.4 Growing Focus of Market Players on 3D Bioprinting
           5.2.2 Restraints
                    5.2.2.1 Lack of Regulatory Guidelines Governing 3D Bioprinting
                    5.2.2.2 Dearth of Trained Professionals
           5.2.3 Opportunities
                    5.2.3.1 Increasing Stem Cell Research
                    5.2.3.2 Growing Awareness Related to 3D Bioprinting
                    5.2.3.3 Rising Adoption of 3D Bioprinting in the Cosmetic Industry
           5.2.4 Challenges
                    5.2.4.1 Socio-Ethical Concerns Related to the Use of 3D Bioprinted Products
                    5.2.4.2 Limitations of Biomaterial-Based Products
                    5.2.4.3 Lack of Complete Automation

6 Industry Insights (Page No. - 43)
    6.1 Introduction
    6.2 3D Bioprinting Approaches
           6.2.1 Biomimicry
           6.2.2 Autonomous Self-Assembly
           6.2.3 Mini-Tissue Building Blocks
    6.3 3D Bioprinting Patent Landscape
    6.4 Industry Trends
           6.4.1 Funding and Investments
           6.4.2 Partnerships, Agreements, and Collaborations
           6.4.3 Conferences and Symposiums

7 3D Bioprinting Market, By Technology (Page No. - 47)
    7.1 Introduction
    7.2 Magnetic 3D Bioprinting
    7.3 Laser-Assisted Bioprinting
    7.4 Inkjet 3D Bioprinting
    7.5 Microextrusion Bioprinting

8 3D Bioprinting Market, By Material (Page No. - 56)
    8.1 Introduction
    8.2 Hydrogels
    8.3 Extracellular Matrices
    8.4 Living Cells
    8.5 Other Biomaterials

9 3D Bioprinting Market, By Application (Page No. - 64)
    9.1 Introduction
    9.2 Clinical Applications
           9.2.1 Skin
           9.2.2 Bone & Cartilage
           9.2.3 Blood Vessels
    9.3 Research Applications
           9.3.1 Drug Research
           9.3.2 Regenerative Medicine
           9.3.3 3D Cell Culture

10 Market By Region (Page No. - 75)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Rest of Europe (RoE)
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 107)
     11.1 Overview
     11.2 Market Ranking Analysis
     11.3 Competitive Situation and Trends
             11.3.1 Agreements, Partnerships, & Collaborations
             11.3.2 Product Launches, Developments, and Commercialization
             11.3.3 Product Showcases, Exhibitions, and Presentations
             11.3.4 Funding
             11.3.5 Other Strategies

12 Company Profiles (Page No. - 114)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
     12.2 Organovo Holdings, Inc.
     12.3 Envisiontec GmbH
     12.4 Nano 3D Biosciences, Inc.
     12.5 Cyfuse Biomedical K.K.
     12.6 Regenhu Ltd.
     12.7 Aspect Biosystems Ltd.
     12.8 Biobots
     12.9 Cellink
     12.10 Gesim
     12.11 Poietis
     12.12 Regenovo Biotechnology Co., Ltd.
     12.13 3Dynamic Systems Ltd.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 135)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Introducing RT: Real-Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports
     13.6 Author Details


List of Tables (74 Tables)

Table 1 3D Bioprinting Patents, 2015–2016
Table 2 3D Bioprinting Market Size, By Technology, 2014-2021 (USD Million)
Table 3 Magnetic 3D Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 4 Laser-Assisted 3D Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 5 Inkjet 3D Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 6 Microextrusion 3D Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 7 3D Bioprinting Market Size, By Material, 2014-2021 (USD Million)
Table 8 Hydrogels Market Size, By Region, 2014–2021 (USD Million)
Table 9 Extracellular Matrices Market Size, By Region, 2014–2021 (USD Million)
Table 10 Living Cells Market Size, By Region, 2014–2021 (USD Million)
Table 11 Other Biomaterials Market Size, By Region, 2014–2021 (USD Million)
Table 12 3D Bioprinting Market Size, By Application, 2014-2021 (USD Million)
Table 13 Clinical Applications Market Size, By Type, 2014-2021 (USD Million)
Table 14 Clinical Applications Market Size, By Region, 2014–2021 (USD Million)
Table 15 Skin Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 16 Bone & Cartilage Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 17 Blood Vessel Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 18 Research Applications Market Size, By Type, 2014-2021 (USD Million)
Table 19 Research Applications Market Size, By Region, 2014–2021 (USD Million)
Table 20 Drug Research Market Size, By Region, 2014–2021 (USD Million)
Table 21 Regenerative Medicine Market Size, By Region, 2014–2021 (USD Million)
Table 22 3D Cell Culture Market Size, By Region, 2014–2021 (USD Million)
Table 23 3D Bioprinting Market Size, By Region, 2014–2021 (USD Million)
Table 24 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 25 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 26 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 27 North America: Market Size, By Material, 2014–2021 (USD Million)
Table 28 U.S.: Market Size, By Technology, 2014–2021 (USD Million)
Table 29 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 30 U.S.: Market Size, By Material, 2014–2021 (USD Million)
Table 31 Canada: Market Size, By Technology, 2014–2021 (USD Million)
Table 32 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 33 Canada: Market Size, By Material, 2014–2021 (USD Million)
Table 34 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 35 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 36 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 37 Europe: Market Size, By Material, 2014–2021 (USD Million)
Table 38 Germany: Market Size, By Technology, 2014–2021 (USD Million)
Table 39 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 40 Germany: Market Size, By Material, 2014–2021 (USD Million)
Table 41 France: Market Size, By Technology, 2014–2021 (USD Million)
Table 42 France: Market Size, By Application, 2014–2021 (USD Million)
Table 43 France: Market Size, By Material, 2014–2021 (USD Million)
Table 44 U.K.: Market Size, By Technology, 2014–2021 (USD Million)
Table 45 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 46 U.K.: Market Size, By Material, 2014–2021 (USD Million)
Table 47 RoE: Market Size, By Technology, 2014–2021 (USD Million)
Table 48 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 49 RoE: Market Size, By Material, 2014–2021 (USD Million)
Table 50 Asia-Pacific: 3D Bioprinting Market Size, By Country, 2014–2021 (USD Million)
Table 51 Asia-Pacific: Market Size, By Technology, 2014–2021 (USD Million)
Table 52 Asia-Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 53 Asia-Pacific: Market Size, By Material, 2014–2021 (USD Million)
Table 54 Japan: Market Size, By Technology, 2014–2021 (USD Million)
Table 55 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 56 Japan: Market Size, By Material, 2014–2021 (USD Million)
Table 57 China: Market Size, By Technology, 2014–2021 (USD Million)
Table 58 China: Market Size, By Application, 2014–2021 (USD Million)
Table 59 China: Market Size, By Material, 2014–2021 (USD Million)
Table 60 India: Market Size, By Technology, 2014–2021 (USD Million)
Table 61 India:  Market Size, By Application, 2014–2021 (USD Million)
Table 62 India: Market Size, By Material, 2014–2021 (USD Million)
Table 63 RoAPAC: Market Size, By Technology, 2014–2021 (USD Million)
Table 64 RoAPAC: Market Size, By Application, 2014–2021 (USD Million)
Table 65 RoAPAC: Market Size, By Material, 2014–2021 (USD Million)
Table 66 RoW: Market Size, By Technology, 2014–2021 (USD Million)
Table 67 RoW: Market Size, By Application, 2014–2021 (USD Million)
Table 68 RoW: Market Size, By Material, 2014–2021 (USD Million)
Table 69 Agreements, Partnerships, and Collaborations, 2013–2016
Table 70 Top 5 Product Launches, Developments, and Commercialization, 2013–2016
Table 71 Product Showcases, Exhibitions, and Presentations, 2013–2016
Table 72 Top 5 Funding, 2013–2016
Table 73 Other Strategies, 2013–2016
Table 74 Product Mix of the 3D Bioprinter Market Players


List of Figures (39 Figures)

Figure 1 Global 3D Bioprinting Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Research Methodology: Bottom-Up Approach
Figure 4 Research Methodology: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Data Triangulation Methodology
Figure 7 Global 3D Bioprinting Market, By Technology
Figure 8 Global Market, By Application
Figure 9 Global Market, By Material
Figure 10 Geographic Snapshot of the Global Market
Figure 11 Rising Demand for Organ Transplantation is Driving Growth in the 3D Bioprinting Market
Figure 12 Microextrusion 3D Bioprinting to Dominate the Global Market in 2016
Figure 13 Living Cells to Command the Largest Share in the 3D Bioprinting Market in 2016
Figure 14 Research Applications Will Continue to Dominate the Global Market in 2021
Figure 15 North America to Command the Largest Share in the Global Market in 2016
Figure 16 Drivers, Restraints, Opportunities, and Challenges
Figure 17 Microextrusion 3D Bioprinting Segment to Witness High Growth During the Forecast Period
Figure 18 Asia-Pacific to Witness High Growth During the Forecast Period
Figure 19 North America to Hold A Major Share in the Laser-Assisted 3D Bioprinting Market
Figure 20 Asia-Pacific to Witness High Growth During the Forecast Period
Figure 21 North America to Hold A Major Share in the Microextrusion 3D Bioprinting Market
Figure 22 Living Cells Segment to Register Highest Growth During the Forecast Period
Figure 23 North America to Hold the Largest Share in the Hydrogels Market, in 2016 and 2021
Figure 24 Asia-Pacific Segment to Register Highest Growth During the Forecast Period
Figure 25 North America to Hold the Largest Share in the Living Cells Market During the Forecast Period
Figure 26 North America to Hold Largest Share of the Other Biomaterials Market in 2016
Figure 27 Research Applications Segment to Witness Highest Growth During the Forecast Period
Figure 28 Skin Segment to Register Highest Growth During the Forecast Period
Figure 29 North America to Command Largest Share During the Forecast Period
Figure 30 Drug Research Segment to Register Highest Growth During the Forecast Period
Figure 31 Asia-Pacific to Witness Highest Growth During the Forecast Period
Figure 32 Market Growth Forecast, By Region (2016–2021)
Figure 33 North America: 3D Bioprinting Market Snapshot
Figure 34 Europe: Market Snapshot
Figure 35 APAC: Market Snapshot
Figure 36 Leading Market Players Adopted Agreement, Collaboration, and Partnership as Their Key Growth Strategy Over the Last Three Years (2013–2016)
Figure 37 Market Ranking By Key Player, 2015
Figure 38 Battle for Market Share: Agreement, Collaboration, and Partnership Was the Key Strategy Adopted By Market Players
Figure 39 Company Snapshot: Organovo Holdings, Inc.

The global 3D bioprinting market is expected to reach USD 1,332.6 Million by 2021 from USD 411.4 Million in 2016, at a CAGR of 26.5% between 2016 and 2021.

On the basis of technology, the global 3D bioprinting market is segmented into four broad categories, namely, microextrusion, inkjet, laser-assisted, and magnetic 3D bioprinting. The microextrusion 3D bioprinting technology is estimated to command the largest share of the global market in 2016 due to its affordability, among other factors. The second-largest share is held by inkjet 3D bioprinting segment, due to its low cost and versatility as compared to other 3D bioprinting techniques.

By application, the market is segmented into clinical applications (including skin, bone, cartilage, and blood vessels) and research applications (including drug research, regenerative medicine, and 3D cell culture). The research applications segment holds the largest share in the 3D bioprinting market. Increasing initiatives by market players and university scientists in 3D bioprinting forms the major factor contributing to the growth of the research applications segment.

By material, the 3D bioprinting market is further segmented into extracellular matrices, hydrogels, living cells, and other biomaterials. The living cells segment is expected to account for the largest share of the market in 2016. Increasing R&D initiatives for the use of living cells in 3D bioprinting is one of the major factors driving the growth of the market. The hydrogels segment is expected to hold the second-largest share in the market, by material.

North America is expected to command the largest share of the 3D bioprinting market in 2016, owing to increasing government initiatives, rising demand for organ transplants, and rising awareness due to conferences and trade shows. Europe is estimated to account for the second-largest share of the market in 2016. The increasing number of 3D bioprinting-related conferences, large number of research activities, and increasing application of 3D bioprinting in the cosmetic industry are some key factors driving the growth of the European market.

The Asia-Pacific 3D bioprinting market is expected to grow at the highest CAGR from 2016 to 2021. The key factors influencing the growth of the Asia-Pacific market are the increase in overall and stem cell research activity, growing demand for organ transplantation, and rising initiatives by market players.

3D Bioprinting Market

Organovo Holdings Inc. (U.S.), EnvisionTEC GmbH (Germany), Nano3D Biosciences, Inc. (U.S.), Cyfuse Biomedical K.K. (Japan), BioBots (U.S.), Aspect Biosystems Ltd. (Canada), 3Dynamic Systems Ltd. (U.K.), regenHU Ltd (Switzerland), Cellink (Sweden), Regenovo Biotechnology Co., Ltd. (China), Poietis (France), and GeSiM (Germany) are some of the key players operating in the global 3D bioprinting market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo